Cargando…

Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome

Metabolic syndrome (MetS) is a clinical manifestation characterized by a plethora of comorbidities, including hyperglycemia, abdominal obesity, arterial hypertension, and dyslipidemia. All MetS comorbidities participate to induce a low-grade inflammation state and oxidative stress, typical of this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Noce, Annalisa, Di Lauro, Manuela, Di Daniele, Francesca, Pietroboni Zaitseva, Anna, Marrone, Giulia, Borboni, Patrizia, Di Daniele, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919668/
https://www.ncbi.nlm.nih.gov/pubmed/33669163
http://dx.doi.org/10.3390/nu13020630
_version_ 1783658168860016640
author Noce, Annalisa
Di Lauro, Manuela
Di Daniele, Francesca
Pietroboni Zaitseva, Anna
Marrone, Giulia
Borboni, Patrizia
Di Daniele, Nicola
author_facet Noce, Annalisa
Di Lauro, Manuela
Di Daniele, Francesca
Pietroboni Zaitseva, Anna
Marrone, Giulia
Borboni, Patrizia
Di Daniele, Nicola
author_sort Noce, Annalisa
collection PubMed
description Metabolic syndrome (MetS) is a clinical manifestation characterized by a plethora of comorbidities, including hyperglycemia, abdominal obesity, arterial hypertension, and dyslipidemia. All MetS comorbidities participate to induce a low-grade inflammation state and oxidative stress, typical of this syndrome. MetS is related to an increased risk of cardiovascular diseases and early death, with an important impact on health-care costs. For its clinic management a poly-pharmaceutical therapy is often required, but this can cause side effects and reduce the patient’s compliance. For this reason, finding a valid and alternative therapeutic strategy, natural and free of side effects, could represent a useful tool in the fight the MetS. In this context, the use of functional foods, and the assumption of natural bioactive compounds (NBCs), could exert beneficial effects on body weight, blood pressure and glucose metabolism control, on endothelial damage, on the improvement of lipid profile, on the inflammatory state, and on oxidative stress. This review focuses on the possible beneficial role of NBCs in the prevention and in the clinical management of MetS and its comorbidities.
format Online
Article
Text
id pubmed-7919668
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79196682021-03-02 Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome Noce, Annalisa Di Lauro, Manuela Di Daniele, Francesca Pietroboni Zaitseva, Anna Marrone, Giulia Borboni, Patrizia Di Daniele, Nicola Nutrients Review Metabolic syndrome (MetS) is a clinical manifestation characterized by a plethora of comorbidities, including hyperglycemia, abdominal obesity, arterial hypertension, and dyslipidemia. All MetS comorbidities participate to induce a low-grade inflammation state and oxidative stress, typical of this syndrome. MetS is related to an increased risk of cardiovascular diseases and early death, with an important impact on health-care costs. For its clinic management a poly-pharmaceutical therapy is often required, but this can cause side effects and reduce the patient’s compliance. For this reason, finding a valid and alternative therapeutic strategy, natural and free of side effects, could represent a useful tool in the fight the MetS. In this context, the use of functional foods, and the assumption of natural bioactive compounds (NBCs), could exert beneficial effects on body weight, blood pressure and glucose metabolism control, on endothelial damage, on the improvement of lipid profile, on the inflammatory state, and on oxidative stress. This review focuses on the possible beneficial role of NBCs in the prevention and in the clinical management of MetS and its comorbidities. MDPI 2021-02-16 /pmc/articles/PMC7919668/ /pubmed/33669163 http://dx.doi.org/10.3390/nu13020630 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Noce, Annalisa
Di Lauro, Manuela
Di Daniele, Francesca
Pietroboni Zaitseva, Anna
Marrone, Giulia
Borboni, Patrizia
Di Daniele, Nicola
Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome
title Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome
title_full Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome
title_fullStr Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome
title_full_unstemmed Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome
title_short Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome
title_sort natural bioactive compounds useful in clinical management of metabolic syndrome
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919668/
https://www.ncbi.nlm.nih.gov/pubmed/33669163
http://dx.doi.org/10.3390/nu13020630
work_keys_str_mv AT noceannalisa naturalbioactivecompoundsusefulinclinicalmanagementofmetabolicsyndrome
AT dilauromanuela naturalbioactivecompoundsusefulinclinicalmanagementofmetabolicsyndrome
AT didanielefrancesca naturalbioactivecompoundsusefulinclinicalmanagementofmetabolicsyndrome
AT pietrobonizaitsevaanna naturalbioactivecompoundsusefulinclinicalmanagementofmetabolicsyndrome
AT marronegiulia naturalbioactivecompoundsusefulinclinicalmanagementofmetabolicsyndrome
AT borbonipatrizia naturalbioactivecompoundsusefulinclinicalmanagementofmetabolicsyndrome
AT didanielenicola naturalbioactivecompoundsusefulinclinicalmanagementofmetabolicsyndrome